Evaluation of prognostic markers for Canine mast cell tumors treated with vinblastine and prednisone

BMC Veterinary Research

Volumn 4, Issue , 2008, Pages

  Webster, Joshua D ^a   Yuzbasiyan Gurkan, Vilma ^a,b   Thamm, Douglas H ^c   Hamilton, Elizabeth ^a   Kiupel, Matti ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Colorado State University ^*  (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

PREDNISONE; STEM CELL FACTOR RECEPTOR; VINBLASTINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EVALUATION; GENE DUPLICATION; GENETICS; KAPLAN MEIER METHOD; MALE; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; URTICARIA PIGMENTOSA;

ANIMALS; DOG DISEASES; DOGS; GENE DUPLICATION; KAPLAN-MEIERS ESTIMATE; MALE; MASTOCYTOSIS, CUTANEOUS; PREDNISONE; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE;

EID: 53549123578     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-4-32     Document Type: Article

References (19)

1. Brodey RS: Canine and feline neoplasia. Adv Vet Sci Comp Med 1970, 14:309-354.
2. Finnie JW, Bostock DE: Skin neoplasia in dogs. Aust Vet J 1979, 55 (12):602-604.
3. Priester WA: Skin tumors in domestic animals. Data from 12 United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst 1973, 50 (2):457-466.
4. Rothwell TL, Howlett CR, Middleton DJ, Griffiths DA, Duff BC: Skin neoplasms of dogs in Sydney. Aust Vet J 1987, 64 (6):161-164.
5. Bostock DE: The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973, 14 (1):27-41.
6. Misdorp W: Mast cells and canine mast cell tumours. A review. Vet Q 2004, 26 (4):156-169.
7. Patnaik AK, Ehler WJ, MacEwen EG: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984, 21 (5):469-474.
8. Thamm DH, Vail DM: Mast cell tumors. In Small Animal Clinical Oncology 3rd edition. Edited by: Withrow SJ, MacEwen EG. Philadelphia, PA, W. B. Saunders; 2001:261-282.
9. Zemke D, Yamini B, Yuzbasiyan-Gurkan V: Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol 2002, 39 (5):529-535.
10. Webster JD, Kiupel M, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V: The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 2004, 41 (4):371-377.
11. Webster JD, Yuzbasiyan-Gurkan V, Kaneene JB, Miller R, Resau JA, Kiupel M: The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 2006, 8 (4):104-111.
12. Webster JD, Yuzbasiyan-Gurkan V, Miller RA, Kaneene JB, Kiupel M: Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication. Vet Pathol 2007, 44 (3):298-308.
13. Thamm DH, Mauldin EA, Vail DM: Prednisone and vinblastine chemotherapy for canine mast cell tumor-41 cases (1992-1997). J Vet Intern Med 1999, 13 (5):491-497.
14. Kiupel M, Webster JD, Miller RA, Kaneene JB: Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. J Vet Med A Physiol Pathol Clin Med 2005, 52 (6):280-286.
15. Kiupel M, Webster JD, Bailey KL, Best S, DeLay J, Detrisac CJ, Gamble D, Ginn PE, Goldschmidt MH, Hendrick MJ, Howerth EW, Janovitz EB, Lenz SD, Lipscomb T, Miller E, Misdorp W, Moroff S, Neyens I, O'Toole D, Ramos-Vara J, Scase TJ, Schulman Y, Smith K, Snyder P, Southorn E, Stedman NL, Steficek BA, Stromberg PC, Valli VE, Weisbrode SE, Yager J, Kaneene JB: Microscopic grading of canine cutaneous mast cell tumors: a multi-institutional review. Vet Pathol 2004, 41:576.
16. Northrup NC, Harmon BG, Gieger TL, Brown CA, Carmichael KP, Garcia A, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Cheng AL, Howerth EW: Variation among pathologists in histologic grading of canine cutaneous mast cell tumors. J Vet Diagn Invest 2005, 17 (3):245-248.
17. Northrup NC, Howerth EW, Harmon BG, Brown CA, Carmicheal KP, Garcia AP, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Gieger TL: Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference. J Vet Diagn Invest 2005, 17 (6):561-564.
18. Seguin B, Leibman NF, Bregazzi VS, Ogilvie GK, Powers BE, Dernell WS, Fettman MJ, Withrow SJ: Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). J Am Vet Med Assoc 2001, 218 (7):1120-1123.
19. Weisse C, Shofer FS, Sorenmo K: Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 2002, 38 (1):71-73.